New York State Common Retirement Fund’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.74M | Hold |
43,004
| – | – | ﹤0.01% | 1459 |
|
|
2025
Q1 | $2.21M | Hold |
43,004
| – | – | ﹤0.01% | 1338 |
|
|
2024
Q4 | $2.38M | Sell |
43,004
-1,600
| -4% | -$88.6K | ﹤0.01% | 1357 |
|
|
2024
Q3 | $1.47M | Buy |
44,604
+5,105
| +13% | +$168K | ﹤0.01% | 1512 |
|
|
2024
Q2 | $1.07M | Buy |
39,499
+20
| +0.1% | +$544 | ﹤0.01% | 1727 |
|
|
2024
Q1 | $1.44M | Buy |
39,479
+12,961
| +49% | +$471K | ﹤0.01% | 1600 |
|
|
2023
Q4 | $537K | Sell |
26,518
-48
| -0.2% | -$972 | ﹤0.01% | 2068 |
|
|
2023
Q3 | $472K | Buy |
26,566
+15,724
| +145% | +$279K | ﹤0.01% | 2076 |
|
|
2023
Q2 | $196K | Sell |
10,842
-2,123
| -16% | -$38.4K | ﹤0.01% | 2507 |
|
|
2023
Q1 | $163K | Hold |
12,965
| – | – | ﹤0.01% | 2673 |
|
|
2022
Q4 | $190K | Buy |
12,965
+17
| +0.1% | +$249 | ﹤0.01% | 2744 |
|
|
2022
Q3 | $222K | Buy |
12,948
+88
| +0.7% | +$1.51K | ﹤0.01% | 2732 |
|
|
2022
Q2 | $188K | Buy |
12,860
+6,979
| +119% | +$102K | ﹤0.01% | 2819 |
|
|
2022
Q1 | $99K | Buy |
5,881
+9
| +0.2% | +$152 | ﹤0.01% | 3021 |
|
|
2021
Q4 | $132K | Sell |
5,872
-9
| -0.2% | -$202 | ﹤0.01% | 3010 |
|
|
2021
Q3 | $127K | Sell |
5,881
-3,472
| -37% | -$75K | ﹤0.01% | 3066 |
|
|
2021
Q2 | $271K | Buy |
9,353
+3,453
| +59% | +$100K | ﹤0.01% | 2907 |
|
|
2021
Q1 | $190K | Buy |
5,900
+2,400
| +69% | +$77.3K | ﹤0.01% | 2854 |
|
|
2020
Q4 | $145K | Buy |
+3,500
| New | +$145K | ﹤0.01% | 2870 |
|